Reduced prophylactic effect of tixagevimab–cilgavimab in patients with hematological malignancies and without antibody response after SARS‐COV‐2 vaccination
European Journal of Haematology · 2023
DOI: 10.1111/ejh.14045 ↗Kurz gefasst
Leserbrief in der Zeitschrift European Journal of Haematology, 2023. Verfasst von Chiara Callegari und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Stem Cell Transplantation Unit, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy. Hauptthemen laut MEDLINE: COVID-19, Hematologic Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Hematology and Stem Cell Transplantation Unit, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
- Division of Hematology, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy.
- Division of Infectious Diseases, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
ORCID-Profile: Chiara Callegari
Zitieren
APA
Callegari, C., Lazzarotto, D., Soravia, A., Mutti, M., Lauzzana, P., Peghin, M., Cordella, S., Fanin, R., & Candoni, A. (2023). Reduced prophylactic effect of tixagevimab–cilgavimab in patients with hematological malignancies and without antibody response after SARS‐COV‐2 vaccination. European Journal of Haematology. https://doi.org/10.1111/ejh.14045
Vancouver
Callegari C, Lazzarotto D, Soravia A, Mutti M, Lauzzana P, Peghin M, et al. Reduced prophylactic effect of tixagevimab–cilgavimab in patients with hematological malignancies and without antibody response after SARS‐COV‐2 vaccination. European Journal of Haematology. 2023. doi:10.1111/ejh.14045
BibTeX
@article{Callegari2023,
author = {Callegari, Chiara and Lazzarotto, Davide and Soravia, Alessandra and Mutti, Martina and Lauzzana, Pietro and Peghin, Maddalena and Cordella, Stefano and Fanin, Renato and Candoni, Anna},
title = {Reduced prophylactic effect of tixagevimab–cilgavimab in patients with hematological malignancies and without antibody response after SARS‐COV‐2 vaccination},
journal = {European Journal of Haematology},
year = {2023},
doi = {10.1111/ejh.14045}
}
EUVIMED